Prolonged Survival of a Patient With Pelvic Recurrence of Ovarian Malignant Mixed Mullerian Tumor After Chemoradiotherapy | Zendy

Fatemeh Homaei Shandiz | Zendy; Sima Kadkhodayan | Zendy; Zohre Yousefi Roodsari | Zendy; Malihe Hsanzade Mofrad | Zendy; Noorieh Sharifi Sistani | Zendy; Majid Nabizadeh Marvast | Zendy; Mahbobe Sadeghei | Zendy

Open Access

Prolonged Survival of a Patient With Pelvic Recurrence of Ovarian Malignant Mixed Mullerian Tumor After Chemoradiotherapy

Author(s) -

Fatemeh Homaei Shandiz,

Sima Kadkhodayan,

Zohre Yousefi Roodsari,

Malihe Hsanzade Mofrad,

Noorieh Sharifi Sistani,

Majid Nabizadeh Marvast,

Mahbobe Sadeghei

Publication year - 2014

Publication title -

iranian red crescent medical journal

Language(s) - English

Resource type - Journals

eISSN - 2074-1812

pISSN - 2074-1804

DOI - 10.5812/ircmj.14919

Subject(s) - medicine , chemotherapy , chemoradiotherapy , cytoreductive surgery , radiation therapy , stage (stratigraphy) , ovary , oncology , surgery , ovarian cancer , cancer , paleontology , biology

Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers.We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 25 months of being disease free, she had a pelvic recurrence and a good response to chemoradiotherapy.Optimal cytoreductive surgery and chemotherapy may be the best treatment in MMMT but more discussion and experiences are needed regarding the effectiveness of radiotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research